OXB collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated ...

Vectors typically fall into the categories of viral and nonviral. Viral vectors commonly used in cell and gene therapy include adenovirus, adeno-associated virus (AAV), lentivirus, and retrovirus, ...

Infection with adenovirus produces M1 differentiation of CAR macrophages ... T cells within this fraction are activated and expanded ex vivo. Next, a lentiviral or retroviral vector carrying the CAR ...

"With our expanded dPCR portfolio, we are not only meeting the needs of lentivirus-based therapies but also reaffirming our long-term commitment as a partner for quality control in CGT development ...

In this study, lentiviral vector–transduced autologous CD34+ HSCT was successful in treating severe LAD-I. (Funded by Rocket Pharmaceuticals and the California Institute for Regenerative ...

Advt "Initially, we suspected pneumonia, but after thorough diagnosis and testing, it was confirmed as an adenovirus infection--a dangerous and often life-threatening condition in infants for ...

Adenovirus was first detected at a median of 54 days (range −4 to +333) after BMT. Adenovirus developed in eight of 69 (11.6%) patients receiving grafts from matched unrelated or mismatched ...

UCL leveraged ViroCell's expertise in lentiviral vector manufacturing for an innovative CAR T-cell therapy for the treatment of paediatric acute lymphoblastic leukaemia ViroCell Biologics ...

They will also provide lentiviral vectors essential for clinical development. CAR-T therapies, which reprogramme a patient’s immune cells to attack cancer cells, have shown remarkable success in ...